NLRP3 and hypertensive disorder: Krishnan et al. noted that MCC950, an inhibitor of the NLRP3 inflammasome, was effective at reducing blood pressure (BP) and limiting renal inflammation, fibrosis, and dysfunction in mice with established hypertension.